Status:
COMPLETED
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Bp Consulting, Inc
Collaborating Sponsors:
Allergan
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study compares the efficacy and tolerability/comfort of brimonidine/timolol and dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. In an investigator masked randomiz...
Eligibility Criteria
Inclusion
- Male or female over 18 yrs.
- Female subjects of childbearing potential must have negative pregnancy test and provide contraception.
- Subjects must have confirmed diagnosis of primary open-angle glaucoma or ocular hypertension in both eyes.
- Subjects who are or have been insufficiently responsive to IOP reducing monotherapy and use of either study medication is deemed appropriate.
- Subjects able to complete questionnaires and provide informed consent.
Exclusion
- Female subjects who are pregnant, planning to become pregnant during study period, breast feeding or not practicing a reliable method of birth control.
- Subjects wherein the study drugs are containdicated.
- Subjects who have had introcular surgery with 6 months (3 months for laser).
- Subjects with known side effects/ allergy or sensitivity to any component of study treatments.
- Subjects with any uncontrolled systemic disease.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00822081
Start Date
January 1 2005
End Date
April 1 2006
Last Update
January 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barrie, Ontario, Canada